Sign in

CIK 0001196298

  • Non-accelerated filer
  • Smaller reporting company

NEPHROS INC

Sign in to watch
Ticker
NEPH
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133971809
Phone
+1 201-343-5202
Business address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
  1. 4 Grant or award Director acquired 42,481 shares (grant or award)
  2. 4 Grant or award Director acquired 27,613 shares (grant or award)
  3. 4 Grant or award Director acquired 27,613 shares (grant or award)
  4. 4 Grant or award Director acquired 8,402 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Exercise or conversion President, CEO & CFO acquired 14,815 shares (option exercise)
  8. 4 Shares withheld for taxes Chief Marketing Officer gave up 6,389 shares (to pay taxes)
  9. 4 Grant or award Director acquired 4,582 shares (grant or award)
  10. 4 Grant or award Director acquired 4,582 shares (grant or award)
  11. 4 Grant or award Director acquired 5,429 shares (grant or award)
  12. 4 Grant or award Director acquired 4,582 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Chief Marketing Officer bought 1,000 shares at $7.92 ($7,920)
  16. 4 Open-market buy Director bought 5,000 shares at $7.64 ($38,200)
  17. 4 Open-market buy President & CEO bought 5,000 shares at an average $7.72 ($38,605)
  18. 4 Option exercise Director acquired 66,667 shares (option exercise)
  19. 4/A Shares withheld for taxes CEO Specialty Renal Products gave up 698 shares (to pay taxes)
  20. 4 Option exercise CEO of Specialty Renal Product acquired 2,222 shares (option exercise)

Page 3 of 17 · 332 filings